H.‐G. Mergenthaler

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

Eckhard Thiel, Agnieszka Korfel, Peter Martus et al. · The Lancet Oncology · 2010 · 622 citations

Medicine, Oncology, Pharmacotherapy +10

Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

Jan Krönke, Richard F. Schlenk, Kai‐Ole Jensen et al. · Journal of Clinical Oncology · 2011 · 394 citations · Full text

Medicine, Hematology, Oncology +15

Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986

Claus Henning Köhne, Eric Van Cutsem, J. Wils et al. · Journal of Clinical Oncology · 2005 · 329 citations

Medicine, Oncology, Pharmacotherapy +16

German Cancer Society Neuro‐Oncology Working Group NOA‐03 multicenter trial of single‐agent high‐dose methotrexate for primary central nervous system lymphoma

Ulrich Herrlinger, Martin Schabet, Wolfram Brugger et al. · Annals of Neurology · 2002 · 182 citations

Medicine, Oncology, Pharmacotherapy +13

Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer

Volker Heinemann, H. Wilke, H.‐G. Mergenthaler et al. · Annals of Oncology · 2000 · 172 citations

Medicine, Oncology, Pharmacology +12